LY3337641

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY3337641, covering 2019-10-09 to 2023-10-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3337641 in Healthy Participants [Phase 1]